Difference between revisions of "Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5 (Q9615)"
Jump to navigation
Jump to search
(Created claim: Publication Date (P100): 2014, #quickstatements; #temporary_batch_1590002823654) |
(Created claim: Published In Name String (P102): Front. Oncol., #quickstatements; #temporary_batch_1590006349955) |
||
| Property / Published In Name String | |||
| + | Front. Oncol. | ||
| Property / Published In Name String: Front. Oncol. / rank | |||
| + | Normal rank | ||
Revision as of 20:38, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
| Language | Label | Description | Also known as |
|---|---|---|---|
| English |
Tasian SK, et al. Front. Oncol. (2014) cited as Ref 352 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Tasian SK
0 references
Teachey DT
0 references
Rheingold SR
0 references
2014
0 references
Front. Oncol.
0 references
